ProfileGDS4718 / 215108_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 93% 68% 94% 96% 92% 96% 94% 95% 96% 95% 94% 93% 94% 92% 93% 96% 96% 91% 94% 94% 94% 96% 94% 96% 93% 94% 93% 95% 92% 95% 91% 95% 95% 95% 96% 91% 92% 94% 54% 94% 95% 94% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.7041992
GSM549102patient 115, normal, homogenized [OPG study]9.6865393
GSM549104patient 119, normal, homogenized [OPG study]6.7268468
GSM549108patient 138, normal, homogenized [OPG study]10.021594
GSM549119patient 077, normal, homogenized [OPG study]10.579596
GSM549133patient 032, cancer, homogenized [OPG study]9.7138492
GSM549139patient 042, cancer, homogenized [OPG study]10.331296
GSM549099patient 107, normal, homogenized [OPG study]9.9743294
GSM549109patient 139, normal, homogenized [OPG study]10.293995
GSM549110patient 046, normal, homogenized [OPG study]10.539796
GSM549114patient 063, normal, homogenized [OPG study]10.385995
GSM549122patient 082, normal, homogenized [OPG study]10.088494
GSM549134patient 033, cancer, homogenized [OPG study]9.6886993
GSM549136patient 036, cancer, homogenized [OPG study]9.9190794
GSM549140patient 044, cancer, homogenized [OPG study]9.5238392
GSM549111patient 047, normal, homogenized [OPG study]9.9765793
GSM549113patient 057, normal, homogenized [OPG study]10.59796
GSM549132patient 031, cancer, homogenized [OPG study]10.503396
GSM549137patient 038, cancer, homogenized [OPG study]9.2422191
GSM549142patient 047, cancer, homogenized [OPG study]9.3914894
GSM549100patient 110, normal, homogenized [OPG study]9.994294
GSM549107patient 135, normal, homogenized [OPG study]10.209394
GSM549115patient 068, normal, homogenized [OPG study]10.645496
GSM549116patient 072, normal, homogenized [OPG study]10.019794
GSM549120patient 078, normal, homogenized [OPG study]10.552796
GSM549131patient 030, cancer, homogenized [OPG study]9.7242293
GSM549118patient 074, normal, homogenized [OPG study]10.133794
GSM549129patient 027, cancer, homogenized [OPG study]9.6806793
GSM549123patient 088, normal, homogenized [OPG study]10.248695
GSM549124patient 006, cancer, homogenized [OPG study]9.4388292
GSM549126patient 015, cancer, homogenized [OPG study]10.060195
GSM549128patient 025, cancer, homogenized [OPG study]9.4092991
GSM549103patient 117, normal, homogenized [OPG study]10.174895
GSM549117patient 073, normal, homogenized [OPG study]10.439695
GSM549138patient 041, cancer, homogenized [OPG study]10.164995
GSM549141patient 045, cancer, homogenized [OPG study]10.500896
GSM549130patient 028, cancer, homogenized [OPG study]9.22291
GSM549101patient 111, normal, homogenized [OPG study]9.4770692
GSM549105patient 128, normal, homogenized [OPG study]10.025594
GSM549106patient 134, normal, homogenized [OPG study]5.7208754
GSM549112patient 048, normal, homogenized [OPG study]10.142794
GSM549125patient 011, cancer, homogenized [OPG study]10.154295
GSM549127patient 024, cancer, homogenized [OPG study]9.751994
GSM549135patient 035, cancer, homogenized [OPG study]9.025888